We are live on ! Find out more
NAM

Needelman Asset Management Portfolio holdings

AUM $46M
1-Year Est. Return 8.27%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
AUM
$40.7M
AUM Growth
+$1.87M
Cap. Flow
+$771K
Cap. Flow %
1.89%
Top 10 Hldgs %
36.13%
Holding
38
New
1
Increased
11
Reduced
16
Closed

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.18M
2
FLR icon
Fluor
FLR
+$99.3K
3
MDLZ icon
Mondelez International
MDLZ
+$55.2K
4
GE icon
GE Aerospace
GE
+$49.2K
5
EMR icon
Emerson Electric
EMR
+$23.8K

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$189K
2
BAC icon
Bank of America
BAC
+$177K
3
ELV icon
Elevance Health
ELV
+$139K
4
MSFT icon
Microsoft
MSFT
+$71.2K
5
BMY icon
Bristol-Myers Squibb
BMY
+$29.2K

Sector Composition

Rank Sector Weight
1 Healthcare 26.59%
2 Financials 22.27%
3 Technology 15.05%
4 Consumer Staples 11.59%
5 Industrials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
1
Bank of America
BAC
$435B
$1.62M 3.97%
63,836
-7,300
-10% -$177K
UNH icon
2
UnitedHealth
UNH
$376B
$1.58M 3.89%
8,077
-980
-11% -$189K
ELV icon
3
Elevance Health
ELV
$81.5B
$1.55M 3.8%
8,140
-730
-8% -$139K
MSFT icon
4
Microsoft
MSFT
$3.45T
$1.54M 3.78%
20,690
-975
-5% -$71.2K
JPM icon
5
JPMorgan Chase
JPM
$935B
$1.5M 3.69%
15,743
-115
-0.7% -$10.6K
ABT icon
6
Abbott
ABT
$183B
$1.43M 3.51%
26,782
MKL icon
7
Markel Group
MKL
$23.3B
$1.43M 3.5%
1,335
-5
-0.4% -$5.17K
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.4M 3.44%
7,645
-50
-0.6% -$8.84K
HON icon
9
Honeywell
HON
$77B
$1.39M 3.42%
10,883
-149
-1% -$18.5K
JNJ icon
10
Johnson & Johnson
JNJ
$618B
$1.27M 3.13%
9,795
-40
-0.4% -$5.3K
VYX icon
11
NCR Voyix
VYX
$1.14B
$1.27M 3.12%
55,216
GILD icon
12
Gilead Sciences
GILD
$162B
$1.25M 3.08%
+15,490
New +$1.18M
INTC icon
13
Intel
INTC
$455B
$1.25M 3.07%
32,845
+100
+0.3% +$3.55K
DEO icon
14
Diageo
DEO
$49B
$1.22M 2.99%
9,202
-40
-0.4% -$5.17K
AON icon
15
Aon
AON
$76.5B
$1.2M 2.94%
8,200
-100
-1% -$14K
CB icon
16
Chubb
CB
$135B
$1.16M 2.84%
8,111
CVX icon
17
Chevron
CVX
$392B
$1.14M 2.81%
9,735
+35
+0.4% +$3.82K
EMR icon
18
Emerson Electric
EMR
$83.9B
$1.12M 2.75%
17,790
+395
+2% +$23.8K
PFE icon
19
Pfizer
PFE
$143B
$1.08M 2.66%
31,963
-105
-0.3% -$3.38K
PG icon
20
Procter & Gamble
PG
$336B
$1.03M 2.53%
11,325
AAPL icon
21
Apple
AAPL
$4.54T
$933K 2.29%
24,224
-100
-0.4% -$3.88K
GE icon
22
GE Aerospace
GE
$374B
$933K 2.29%
8,052
+407
+5% +$49.2K
FLR icon
23
Fluor
FLR
$7.01B
$922K 2.26%
21,905
+2,395
+12% +$99.3K
BMY icon
24
Bristol-Myers Squibb
BMY
$133B
$905K 2.22%
14,200
-500
-3% -$29.2K
ABBV icon
25
AbbVie
ABBV
$443B
$894K 2.2%
10,057

Similar funds

Needelman Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Needelman Asset Management held 38 positions worth $40.7M, up 4.8% from $38.8M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. Needelman Asset Management opened 1 new position and made no exits, leaving the 38-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

  • Needelman Asset Management's largest Q3 2017 buy was Gilead Sciences: 15,490 shares worth $1.25M.
  • Needelman Asset Management added most to Fluor in Q3 2017, an estimated $99.3K increase.
  • Needelman Asset Management's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $189K.
  • Needelman Asset Management's ten largest holdings make up 36% of its $40.7M portfolio in Q3 2017.
  • Needelman Asset Management opened 1 new position and closed 0 in Q3 2017.
  • Needelman Asset Management's portfolio value rose 4.8% quarter-over-quarter to $40.7M.

Based on Needelman Asset Management's 13F filing for Q3 2017, filed 5 Oct 2017.